✦ LIBER ✦

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial

✍ Scribed by Conny Vrieling; Laurence Collette; Alain Fourquet; Willem J. Hoogenraad; Jean-Claude Horiot; Jos J. Jager; Marianne Pierart; Philip M. Poortmans; Henk Struikmans; Ben Maat; Erik Van Limbergen; Harry Bartelink

Book ID: 119510692
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 142 KB
Volume: 55
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(00)00210-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of the boost technique on

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ trial

✍ P.M Poortmans; H Bartelink; J.C Horiot; H Struikmans; W Van den Bogaert; A Fourq 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

The influence of the boost technique on

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial

✍ Philip Poortmans; Harry Bartelink; Jean-Claude Horiot; Henk Struikmans; Walter V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

The impact of a boost dose on the local

The impact of a boost dose on the local recurrence rate in high risk patients after breast conserving therapy – results from the EORTC boost-no boost trial

✍ H. Jones; N. Antonini; L. Collette; A. Fourquet; W.J. Hoogenraad; J.J. Jager; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Long-term cosmetic changes after breast

Long-term cosmetic changes after breast conserving therapy for patients with stage I and II breast cancer treated in the EORTC “boost versus no boost” trial

✍ M. Immink; H. Putter; J. Visser; H. Bartelink; J. Cardoso; M.J. Cardoso; E.M. No 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Impact of Pathological Characteristics o

Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

✍ Moran, M.S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The addition of a boost dose on the prim

The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial

✍ P.M. Poortmans; L. Collette; H. Bartelink; H. Struikmans; W.F. Van den Bogaert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 225 KB